Richard D. Gill

Richard D. Gill

Directeur/Membre du Conseil chez
Cognoptix, Inc.
Commercial Services
Finance
Health Technology

Profil

Richard D.
Gill
currently works at Cognoptix, Inc., as Director and Lovelace Respiratory Research Institute, as Director.
Dr. Gill also formerly worked at Sierra Oncology, Inc., as President & Chief Executive Officer, TruTouch Technologies, Inc., as President, Chief Executive Officer & Director from 2011 to 2013, BioLegend CNS, Inc., as President & Chief Executive Officer, ActiveCyte, Inc., as President & Chief Executive Officer, AnVil, Inc., as President & Chief Executive Officer, SynDevRx, Inc., as Director, NABsys, Inc., as Director, Launchpad Venture Group LLC, as Director, Era Biotech SA, as Director, Oscient Pharmaceuticals Corp., as President & Chief Operating Officer, Unilever Plc, as Principal, BTG International, Inc., as Senior Vice President & General Manager, and Rittenhouse Ventures LLC, as Advisor.
Dr. Gill received his undergraduate degree and doctorate degree from The University of Reading.

Postes actifs de Richard D. Gill

SociétésPosteDébut
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -

Anciens postes connus de Richard D. Gill

SociétésPosteFin
Private Equity Investor 30/04/2008
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
UNILEVER PLC Corporate Officer/Principal -
President -
Voir l'expérience en détail de Richard D. Gill

Formation de Richard D. Gill

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

17

Relations au 1er degré

16

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées16

Commercial Services

Consumer Non-Durables

Health Technology

Health Services

Commercial Services

Commercial Services

Consumer Services

Finance

Health Technology

Commercial Services

Commercial Services

Finance

Finance

ActiveCyte, Inc.

Commercial Services

Technology Services

  1. Bourse
  2. Insiders
  3. Richard D. Gill
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇